• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Istradefylline for Restless Legs Syndrome Associated with Parkinson's Disease.

作者信息

Nuermaimaiti Maierdanjiang, Oyama Genko, Kasemsuk Chayut, Hattori Nobutaka

机构信息

Department of Neurology, Juntendo University, Tokyo, Japan.

Department of Neurology, Prasat Neurological Institute, Bangkok, Thailand.

出版信息

Tremor Other Hyperkinet Mov (N Y). 2018 Jan 8;8:521. doi: 10.7916/D86H5R1H. eCollection 2018.

DOI:10.7916/D86H5R1H
PMID:29423337
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5803507/
Abstract
摘要

相似文献

1
Istradefylline for Restless Legs Syndrome Associated with Parkinson's Disease.用于治疗与帕金森病相关的不宁腿综合征的伊曲茶碱
Tremor Other Hyperkinet Mov (N Y). 2018 Jan 8;8:521. doi: 10.7916/D86H5R1H. eCollection 2018.
2
Istradefylline: adenosine A2A receptor antagonist to reduce "OFF" time in Parkinson's disease.异他林：一种腺苷A2A受体拮抗剂，用于减少帕金森病的“关”期时间。
Drugs Today (Barc). 2020 Feb;56(2):125-134. doi: 10.1358/dot.2020.56.2.3098156.
3
Two new adenosine receptor antagonists for the treatment of Parkinson's disease: istradefylline versus tozadenant.两种用于治疗帕金森病的新型腺苷受体拮抗剂：异他茶碱与托扎腺苷
Expert Opin Pharmacother. 2014 Jun;15(8):1097-107. doi: 10.1517/14656566.2014.903924. Epub 2014 Mar 27.
4
Occupancy of adenosine A receptors by istradefylline in patients with Parkinson's disease using C-preladenant PET.使用 C 优先正电子发射断层扫描术研究伊曲茶碱在帕金森病患者体内对腺苷 A 受体的占据情况。
Neuropharmacology. 2018 Dec;143:106-112. doi: 10.1016/j.neuropharm.2018.09.036. Epub 2018 Sep 22.
5
Does istradefylline really have a dystonic mechanism?
J Neurol Sci. 2018 May 15;388:233-234. doi: 10.1016/j.jns.2018.03.020. Epub 2018 Mar 14.
6
Istradefylline (Nourianz) for Parkinson's disease.用于帕金森病的伊曲茶碱（Nourianz）
Med Lett Drugs Ther. 2020 Feb 10;62(1591):20-23.
7
The effect of istradefylline for Parkinson's disease: A meta-analysis.依曲替酯治疗帕金森病的疗效：一项荟萃分析。
Sci Rep. 2017 Dec 21;7(1):18018. doi: 10.1038/s41598-017-18339-1.
8
Istradefylline for the treatment of Parkinson's disease.依曲司他滨治疗帕金森病。
Expert Opin Pharmacother. 2012 Jan;13(1):111-4. doi: 10.1517/14656566.2012.643869.
9
The role of istradefylline in the Parkinson's disease armamentarium.依曲替酯在帕金森病治疗中的作用。
Expert Opin Pharmacother. 2023 May;24(7):863-871. doi: 10.1080/14656566.2023.2201374. Epub 2023 Apr 18.
10
Istradefylline - a first generation adenosine A antagonist for the treatment of Parkinson's disease.依达拉奉 - 一种用于治疗帕金森病的第一代腺嘌呤 A 拮抗剂。
Expert Rev Neurother. 2021 Mar;21(3):317-333. doi: 10.1080/14737175.2021.1880896. Epub 2021 Feb 22.

引用本文的文献

1
Pharmacological and Non-pharmacological Treatments of Sleep Disorders in Parkinson's Disease.帕金森病睡眠障碍的药物和非药物治疗。
Curr Neuropharmacol. 2021;19(12):2233-2249. doi: 10.2174/1570159X19666210517115706.
2
Design, Synthesis, and Biological Activity Studies of Istradefylline Derivatives Based on Adenine as A Receptor Antagonists.基于腺嘌呤作为受体拮抗剂的异他林衍生物的设计、合成及生物活性研究
ACS Omega. 2021 Feb 4;6(6):4386-4394. doi: 10.1021/acsomega.0c05741. eCollection 2021 Feb 16.

本文引用的文献

1
Adenosine receptors as markers of brain iron deficiency: Implications for Restless Legs Syndrome.腺苷受体作为脑铁缺乏的标志物：对不宁腿综合征的影响。
Neuropharmacology. 2016 Dec;111:160-168. doi: 10.1016/j.neuropharm.2016.09.002. Epub 2016 Sep 4.
2
Clinical characteristics of leg restlessness in Parkinson's disease compared with idiopathic Restless Legs Syndrome.帕金森病中腿部不安与特发性不宁腿综合征相比的临床特征。
J Neurol Sci. 2015 Oct 15;357(1-2):109-14. doi: 10.1016/j.jns.2015.07.008. Epub 2015 Jul 9.
3
Emergence of restless legs syndrome after subthalamic stimulation in Parkinson's disease: a dopaminergic overstimulation?帕金森病丘脑底核刺激后出现不宁腿综合征：多巴胺能过度刺激？
Sleep Med. 2015 May;16(5):583-8. doi: 10.1016/j.sleep.2014.11.020. Epub 2015 Mar 3.
4
Effectiveness and tolerability of istradefylline for the treatment of restless legs syndrome: an exploratory study in five female patients.异他茶碱治疗不宁腿综合征的有效性和耐受性：一项针对五名女性患者的探索性研究。
Curr Ther Res Clin Exp. 2007 Sep;68(5):349-59. doi: 10.1016/j.curtheres.2007.11.001.
5
Adenosine A2A receptor antagonist istradefylline reduces daily OFF time in Parkinson's disease.腺苷 A2A 受体拮抗剂伊曲茶碱可减少帕金森病患者的每日关闭时间。
Mov Disord. 2013 Jul;28(8):1138-41. doi: 10.1002/mds.25418. Epub 2013 Mar 11.
6
Restless Legs Syndrome (RLS) and Parkinson's disease (PD)-related disorders or different entities?不宁腿综合征（RLS）与帕金森病（PD）相关障碍或不同实体？
J Neurol Sci. 2010 Feb 15;289(1-2):135-7. doi: 10.1016/j.jns.2009.08.035. Epub 2009 Sep 15.
7
Restless legs syndrome in Parkinson's disease and other neurodegenerative diseases of the central nervous system.帕金森病及其他中枢神经系统神经退行性疾病中的不宁腿综合征
Mov Disord. 2007;22 Suppl 18:S424-30. doi: 10.1002/mds.21600.
8
Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome.国际不宁腿综合征研究组不宁腿综合征评定量表的验证
Sleep Med. 2003 Mar;4(2):121-32. doi: 10.1016/s1389-9457(02)00258-7.